Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement

There is a paucity of real‐world data regarding the temporal trends and outcomes of trans‐septal transcatheter mitral valve replacement (TS‐TMVR) in the United States (US).

[1]  J. Leipsic,et al.  Transcatheter Mitral Valve Replacement: An Update on Current Techniques, Technologies, and Future Directions. , 2021, JACC. Cardiovascular interventions.

[2]  H. Jneid,et al.  Trends and Outcomes of Transcatheter Valve Implantation in Patients with Prior Mediastinal Radiation. , 2021, The American journal of cardiology.

[3]  Brian C. Case,et al.  LAMPOON techniques to prevent or manage left ventricular outflow tract obstruction in transcatheter mitral valve replacement. , 2021, Annals of cardiothoracic surgery.

[4]  A. Pershad,et al.  Short term outcomes after transcatheter mitral valve repair. , 2020, International journal of cardiology.

[5]  S. Kapadia,et al.  Transcatheter Edge-to-Edge Repair With MitraClip in Systolic Heart Failure With Ischemic Versus Nonischemic Cardiomyopathy. , 2020, JACC. Cardiovascular interventions.

[6]  G. Gerosa,et al.  Surgical redo versus transseptal or transapical transcatheter mitral valve‐in‐valve implantation for failed mitral valve bioprosthesis , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  M. Mack,et al.  One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. , 2020, JAMA cardiology.

[8]  J. Cavalcante,et al.  Neo-Left Ventricular Outflow Tract modification With Alcohol Septal Ablation Before Tendyne Transcatheter Mitral Valve Replacement. , 2020, JACC. Cardiovascular interventions.

[9]  M. Guerrero,et al.  Pre-Emptive Radiofrequency Septal Ablation to Decrease the Risk of Left Ventricular Outflow Tract Obstruction After TMVR. , 2020, JACC. Cardiovascular interventions.

[10]  W. O’Neill,et al.  Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States , 2020, Circulation. Cardiovascular interventions.

[11]  E. Tuzcu,et al.  The Impact of Hospital Characteristics on the Outcomes of Interventional Cardiac Procedures. , 2019, JACC. Cardiovascular interventions.

[12]  M. Guerrero,et al.  Preemptive alcohol septal ablation to prevent left ventricular outflow tract obstruction after transseptal mitral valve in valve. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[13]  J. Rodés‐Cabau,et al.  Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review , 2019, Journal of the American Heart Association.

[14]  J. Leipsic,et al.  Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. , 2019, Journal of the American College of Cardiology.

[15]  I. Palacios,et al.  1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. , 2018, Journal of the American College of Cardiology.

[16]  G. Reeder,et al.  Procedural trends, outcomes, and readmission rates pre‐and post‐FDA approval for MitraClip from the National Readmission Database (2013–14) , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  A. Cribier,et al.  Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement. , 2017, JACC. Cardiovascular interventions.

[18]  Deepak L. Bhatt,et al.  Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement , 2017, JAMA cardiology.

[19]  John D Carroll,et al.  2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2017, Journal of the American College of Cardiology.

[20]  John D Carroll,et al.  2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2017, The Annals of thoracic surgery.

[21]  A. Delago,et al.  Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. , 2016, JACC. Cardiovascular interventions.

[22]  B. Whisenant,et al.  Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. , 2016, JACC. Cardiovascular interventions.

[23]  E. de Marchena,et al.  First-in-human off-pump transcatheter mitral valve replacement. , 2014, JACC. Cardiovascular interventions.

[24]  H. Schneider,et al.  First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. , 2013, Circulation.

[25]  D. Wood,et al.  5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. , 2013, Journal of the American College of Cardiology.

[26]  R. Whistance,et al.  Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. , 2012, Interactive cardiovascular and thoracic surgery.

[27]  R. Whistance,et al.  Surgery for non-rheumatic calcific mitral stenosis. , 2011, The Journal of heart valve disease.

[28]  J. M. Bernal,et al.  Repeat mitral valve replacement: 30-years' experience. , 2009, Revista espanola de cardiologia.

[29]  O. Goksel,et al.  Determinants of Hospital Mortality after Repeat Mitral Valve Surgery for Rheumatic Mitral Valve Disease , 2006, The Thoracic and cardiovascular surgeon.

[30]  B. Whisenant,et al.  Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. , 2017, JACC. Cardiovascular interventions.